Search Results - "WONG, MARIWIL G."
-
1
Expression of Vascular Endothelial Growth Factor-C in Benign and Malignant Thyroid Tumors
Published in The journal of clinical endocrinology and metabolism (01-08-2003)“…In contrast to vascular endothelial growth factor (VEGF), which stimulates angiogenesis, VEGF-C is thought to stimulate lymphangiogenesis. The role of VEGF-C…”
Get full text
Journal Article -
2
Valproic acid inhibits growth, induces apoptosis, and modulates apoptosis-regulatory and differentiation gene expression in human thyroid cancer cells
Published in Surgery (01-12-2005)“…Among the most promising new therapies for thyroid cancer are the histone deacetylase inhibitors. Valproic acid (VA) is an anticonvulsant that inhibits histone…”
Get full text
Journal Article -
3
Troglitazone, the peroxisome proliferator-activated receptor-gamma agonist, induces antiproliferation and redifferentiation in human thyroid cancer cell lines
Published in Thyroid (New York, N.Y.) (01-03-2005)“…Troglitazone is a potent agonist for the peroxisome proliferator-activated receptor-gamma (PPARgamma) that is a ligand-activated transcription factor…”
Get more information
Journal Article -
4
The Heat Shock Protein 90-Binding Geldanamycin Inhibits Cancer Cell Proliferation, Down-Regulates Oncoproteins, and Inhibits Epidermal Growth Factor-Induced Invasion in Thyroid Cancer Cell Lines
Published in The journal of clinical endocrinology and metabolism (01-07-2003)“…Heat shock protein 90 (HSP90) serves as a chaperone protein and plays a critical role in tumor cell growth and/or survival. Geldanamycin, a specific inhibitor…”
Get full text
Journal Article -
5
Chromosomal aberrations by comparative genomic hybridization in Hürthle cell thyroid carcinomas are associated with tumor recurrence
Published in The journal of clinical endocrinology and metabolism (01-10-2002)“…Hürthle cell thyroid neoplasms are classified as variants of follicular neoplasms, but they have distinct clinicopathological features. Chromosomal aberrations…”
Get full text
Journal Article -
6
GCMB gene, a master regulator of parathyroid gland development, expression, and regulation in hyperparathyroidism
Published in Surgery (01-12-2004)“…The glial cell missing gene, GCMB, encodes a transcription factor, which is a master regulator of parathyroid development. We postulated that the GCMB gene…”
Get full text
Journal Article -
7
Diagnostic and Prognostic Value of Fas and Telomeric-Repeat Binding Factor-1 Genes in Adrenal Tumors
Published in The journal of clinical endocrinology and metabolism (01-08-2003)“…It is often difficult to distinguish histologically between an adrenal cortical cancer and a benign adenoma, or to predict the prognosis of patients with…”
Get full text
Journal Article -
8
Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines
Published in Surgery (01-12-1996)“…Background. Vascular endothelial growth factor (VEGF) is a vascular endothelial cell-specific mitogen secreted by some cancer cells and is a major regulator of…”
Get full text
Journal Article -
9
Modulation of tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by chemotherapy in thyroid cancer cell lines
Published in Thyroid (New York, N.Y.) (01-12-2003)“…Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces apoptosis in many human cancer cells but not in normal cells. Thyroid cancer cells,…”
Get more information
Journal Article -
10
A Sensitive and Specific Polymerase Chain Reaction-Based Assay for the Diagnosis of Cytomegalovirus Retinitis
Published in American journal of ophthalmology (01-08-1995)“…To develop a sensitive and specific laboratory assay for the diagnosis of cytomegalovirus retinitis. We used a polymerase chain reaction-based assay for…”
Get full text
Journal Article -
11
Desensitization in Normal and Neoplastic Human Thyroid Cell Lines
Published in World journal of surgery (01-06-1998)“…Because some papillary thyroid cancers continue to grow when thyroid‐stimulating hormone (TSH) levels are suppressed, we questioned whether desensitization…”
Get full text
Journal Article -
12
Antiproliferative effect of suramin on primary cultures of human pheochromocytomas and rat PC12 pheochromocytoma cells
Published in Journal of surgical oncology (01-09-1997)“…Background Suramin inhibits growth of neural crest‐derived cells and is used to treat adrenocortical cancer and neuroblastoma in clinical trials. The…”
Get full text
Journal Article -
13
Vascular endothelial growth factor expression is higher in differentiated thyroid cancer than in normal or benign thyroid
Published in The journal of clinical endocrinology and metabolism (01-11-1997)“…Vascular endothelial growth factor (VEGF) is an angiogenic factor, and its expression has been rarely demonstrated in thyroid tumors. We, therefore,…”
Get full text
Journal Article -
14
Induction of apoptosis in human follicular thyroid cancer cells by the histone deacetylase inhibitors TSA and FK228
Published in Journal of the American College of Surgeons (01-09-2004)“…Introduction: The histone deacetylase (HDAC) inhibitors are a heterogeneous group of compounds that alter the chromatin structure of neoplastic cells, causing…”
Get full text
Journal Article -
15
Neutralizing vascular endothelial growth factor activity inhibits thyroid cancer growth in vivo
Published in Surgery (01-12-2000)“…Background. Without angiogenesis, tumor growth is limited to a few millimeters, the limit of diffusion. Vascular endothelial growth factor (VEGF) is an…”
Get full text
Journal Article -
16
Chromosomal Aberrations by Comparative Genomic Hybridization in Hürthle Cell Thyroid Carcinomas Are Associated with Tumor Recurrence
Published in The journal of clinical endocrinology and metabolism (01-10-2002)“…Hürthle cell thyroid neoplasms are classified as variants of follicular neoplasms, but they have distinct clinicopathological features. Chromosomal…”
Get full text
Journal Article -
17
A Val 677 activating mutation of the thyrotropin receptor in a Hürthle cell thyroid carcinoma associated with thyrotoxicosis
Published in Thyroid (New York, N.Y.) (01-01-1999)“…Thyroid nodules presenting as hot at 131I-scintigraphy are usually benign follicular adenomas. We report a 42-year-old female patient with an autonomously…”
Get more information
Journal Article -
18
Phenylacetate enhances the antiproliferative effect of retinoic acid in follicular thyroid cancer
Published in Surgery (01-12-2001)“…Background. Retinoic acid (RA) has antiproliferative as well as redifferentiating effects in thyroid cancers. Similar effects have been seen with phenylacetate…”
Get full text
Journal Article -
19
Phenylacetate inhibits growth and vascular endothelial growth factor secretion in human thyroid carcinoma cells and modulates their differentiated function
Published in The journal of clinical endocrinology and metabolism (01-08-1999)“…There is increasing evidence that phenylacetate inhibits growth and modulates differentiation in a variety of tumors with effects on gene expression, and…”
Get full text
Journal Article -
20
Phenylacetate Inhibits Growth and Vascular Endothelial Growth Factor Secretion in Human Thyroid Carcinoma Cells and Modulates Their Differentiated Function1
Published in The journal of clinical endocrinology and metabolism (01-08-1999)“…There is increasing evidence that phenylacetate inhibits growth and modulates differentiation in a variety of tumors with effects on gene expression, and…”
Get full text
Journal Article